{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-001522","form_type":"8-K","ticker":"CRDF","cik":"0001213037","company_name":"Cardiff Oncology, Inc.","filed_at":"2022-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.616335+00:00","generated_at":"2026-06-27T13:26:19.501407+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Cardiff Oncology grants 55,008 stock options to new employee as inducement","bullets":["Non-qualified stock options for 55,008 shares granted on Jan 31, 2022 to one new employee.","Exercise price of $3.38 per share, equal to Jan 31 closing price.","Options vest over 4 years: 25% at 1-year anniversary, remainder monthly over 36 months.","Grant made under Nasdaq Listing Rule 5635(c)(4) as inducement material to employment."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-001522","json":"https://secwatch.observer/filing/0001628280-22-001522.json","markdown":"https://secwatch.observer/filing/0001628280-22-001522.md","text":"https://secwatch.observer/filing/0001628280-22-001522.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022001522/0001628280-22-001522-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213037/000162828022001522/crdf-20220131.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T13:26:19.501407+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}